Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
59
NHC Quote, Financials, Valuation and Earnings
Last price:
$112.07
Seasonality move
:
-0.77%
Day range:
$111.65 - $114.40
52-week range:
$87.03 - $138.49
Dividend yield:
2.15%
P/E ratio:
14.02x
P/S ratio:
1.42x
P/B ratio:
1.76x
Volume:
241.5K
Avg. volume:
53.3K
1-year change:
17.35%
Market cap:
$1.7B
Revenue:
$1.1B
EPS (TTM):
$7.98
Analysts' Opinion
-
Consensus RatingNational Healthcare has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, National Healthcare has an estimated downside of -- from its current price of $111.87.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $111.87.
Fair Value
-
According to the consensus of 0 analysts, National Healthcare has -- downside to fair value with a price target of -- per share.
NHC vs. S&P 500
-
Over the past 5 trading days, National Healthcare has underperformed the S&P 500 by -6.01% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
National Healthcare does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
National Healthcare has grown year-over-year revenues for 7 quarters straight. In the most recent quarter National Healthcare reported revenues of $340.2M.
Earnings Growth
-
National Healthcare has grown year-over-year earnings for 0 quarters straight. In the most recent quarter National Healthcare reported earnings per share of $2.73.
Enterprise value:
1.6B
EV / Invested capital:
1.44x
Price / LTM sales:
1.42x
EV / EBIT:
9.64x
EV / Revenue:
1.32x
PEG ratio (5yr expected):
0.08x
EV / Free cash flow:
17.66x
Price / Operating cash flow:
18.88x
Enterprise value / EBITDA:
7.71x
Gross Profit (TTM):
$466.3M
Return On Assets:
9.12%
Net Income Margin (TTM):
10.11%
Return On Equity:
13.34%
Return On Invested Capital:
12.93%
Operating Margin:
6.7%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $1.1B | $1.1B | $1.2B | $288.5M | $340.2M | |
| Gross Profit | -- | $411.5M | $466.3M | $105.8M | $126.8M | |
| Operating Income | -- | $42.7M | $81.2M | $13.1M | $22.8M | |
| EBITDA | -- | $100.6M | $211.2M | $24.2M | $70.4M | |
| Diluted EPS | -- | $2.91 | $7.98 | $0.68 | $2.73 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $422.2M | $424.8M | $344.5M | $382.6M | $445.7M | |
| Total Assets | $1.3B | $1.4B | $1.3B | $1.3B | $1.6B | |
| Current Liabilities | $259.7M | $257.7M | $210.2M | $204.7M | $247.9M | |
| Total Liabilities | $561.6M | $513.9M | $414.2M | $394.6M | $575.9M | |
| Total Equity | $777.2M | $901.9M | $881.3M | $887.3M | $986.8M | |
| Total Debt | -- | -- | -- | -- | $147M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $12.3M | $97.4M | $120.2M | $32.3M | $34.2M | |
| Cash From Investing | -- | -$4.6M | -$235.2M | -$5.1M | -$224.1M | |
| Cash From Financing | -- | -$44.8M | $109.8M | -$9.8M | $139.3M | |
| Free Cash Flow | -- | $72.5M | $92.2M | $25.8M | $28.6M | |
NHC
Sector
Market Cap
$1.7B
$44.6M
Price % of 52-Week High
80.78%
45.71%
Dividend Yield
2.15%
0%
Shareholder Yield
0.39%
-0.68%
1-Year Price Total Return
17.35%
-29.09%
Beta (5-Year)
0.427
0.772
Dividend yield:
2.15%
Annualized payout:
$2.34
Payout ratio:
29.44%
Growth streak:
7 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$118.51
200-day SMA
Sell
Level
$113.44
Bollinger Bands (100)
Sell
Level
119.65 - 129.81
Chaikin Money Flow
Buy
Level
6.1M
20-day SMA
Sell
Level
$122.53
Relative Strength Index (RSI14)
Sell
Level
28.91
ADX Line
Sell
Level
13.78
Williams %R
Buy
Level
-98.5903
50-day SMA
Sell
Level
$123.00
MACD (12, 26)
Sell
Level
-2.58
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Neutral
Level
6.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.1314)
Buy
CA Score
(Annual)
Level (1.0617)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-1.8459)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.
Stock Forecast FAQ
In the current month, NHC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NHC average analyst price target in the past 3 months is --.
-
Where Will National Healthcare Stock Be In 1 Year?
According to analysts, the consensus estimate is that National Healthcare share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About National Healthcare?
Analysts are divided on their view about National Healthcare share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that National Healthcare is a Sell and believe this share price will rise from its current level to --.
-
What Is National Healthcare's Price Target?
The price target for National Healthcare over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NHC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for National Healthcare is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NHC?
You can purchase shares of National Healthcare via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase National Healthcare shares.
-
What Is The National Healthcare Share Price Today?
National Healthcare was last trading at $112.07 per share. This represents the most recent stock quote for National Healthcare. Yesterday, National Healthcare closed at $111.87 per share.
-
How To Buy National Healthcare Stock Online?
In order to purchase National Healthcare stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
